UMC ( UMC ) Thursday reported January 2026 sales of NT$20.86 billion, up 5.3% from NT$19.81 billion a year earlier, reflecting a year-on-year increase of NT$1.06 billion. Source: Press Release More on United Microelectronics United Microelectronics: A Clash Of Expectations And Reality; Reality Wins (Rating Upgrade) United Microelectronics Corporation 2025 Q4 - Results - Earnings Call Presentation ...
UMC ( UMC ) Thursday reported January 2026 sales of NT$20.86 billion, up 5.3% from NT$19.81 billion a year earlier, reflecting a year-on-year increase of NT$1.06 billion. Source: Press Release More on United Microelectronics United Microelectronics: A Clash Of Expectations And Reality; Reality Wins (Rating Upgrade) United Microelectronics Corporation 2025 Q4 - Results - Earnings Call Presentation United Microelectronics Corporation (UMC) Q4 2025 Earnings Call Transcript United Microelectronics falls amid mixed Q4 results United Microelectronics reports mixed Q4 results; initiates Q1 outlook
Microsoft's stock got slammed after the company slightly missed expectations in its latest quarter. After Microsoft (MSFT +0.72%) reported its fiscal 2026 second-quarter results on Jan. 28, its stock crashed by 10%. That was a significant tumble for the world's fourth-largest company. However, the question investors must ask now is whether that pullback was warranted or not. As of Monday afternoon...
Microsoft's stock got slammed after the company slightly missed expectations in its latest quarter. After Microsoft (MSFT +0.72%) reported its fiscal 2026 second-quarter results on Jan. 28, its stock crashed by 10%. That was a significant tumble for the world's fourth-largest company. However, the question investors must ask now is whether that pullback was warranted or not. As of Monday afternoon, Microsoft's stock sits almost 22% below its all-time high. That discount may look enticing, but is it a trap? Microsoft's results weren't that bad This tech giant has products ranging from business software and gaming stations to social media sites and cloud computing infrastructure. Its cloud computing segment is what most investors have had their eyes on lately because that unit's results offer investors an indication of the overall demand for artificial intelligence (AI) computing. Many companies that are training and running AI models choose to do so on server clusters rented from cloud infrastructure providers, as this spares AI developers from having to build their own expensive data centers. Microsoft is one of the three largest hyperscalers, and it's happy to foot the up-front bills in exchange for the chance to rent out the resulting computing power. Azure, Microsoft's cloud computing division, has become a top reason to own the stock, and it didn't disappoint in fiscal Q2. For the period, which ended Dec. 31, Azure revenue was up 39% year over year. Furthermore, its remaining performance obligations -- in other words, how much money is left to be earned on the various contracts it has already signed -- rose by 11% to $625 billion. That indicates that there are still tons of AI workloads to churn through, and Azure is far from done growing. Still, Wall Street analysts were looking for slightly faster growth, and Microsoft's mild underperformance resulted in the stock plummeting. However, management noted that if the company had made more of the computing capacity...
Silver fell sharply and suddenly earlier in the session, dropping by about 17% and wiping out a two-day recovery in whatâs been an extremely volatile week for precious metals. It had briefly snuck back above $90/oz, but rapidly fell and is now trading at around $79/oz. The metal is still about a third lower than the peak hit last week. Gold is in a much calmer mood, edging a touch higher though ...
Silver fell sharply and suddenly earlier in the session, dropping by about 17% and wiping out a two-day recovery in whatâs been an extremely volatile week for precious metals. It had briefly snuck back above $90/oz, but rapidly fell and is now trading at around $79/oz. The metal is still about a third lower than the peak hit last week. Gold is in a much calmer mood, edging a touch higher though once again short of $5,000.
aapl Apple Stock Breakout: AAPL Eyes Record High As Tech Falls – No Siri Talk From Google Despite a wider tech selloff, Apple shares are still rising, which is forcing investors to balance the company's solid foundation against... Written by: Skerdian Meta • • 4 min read • Quick overview Apple shares have risen 2.6% to $276.40, outperforming the Nasdaq Composite amid a broader tech selloff. A rece...
aapl Apple Stock Breakout: AAPL Eyes Record High As Tech Falls – No Siri Talk From Google Despite a wider tech selloff, Apple shares are still rising, which is forcing investors to balance the company's solid foundation against... Written by: Skerdian Meta • • 4 min read • Quick overview Apple shares have risen 2.6% to $276.40, outperforming the Nasdaq Composite amid a broader tech selloff. A recent policy shift in India allows foreign companies to supply machinery without tax liabilities, enhancing Apple's manufacturing strategy in the region. Apple's fiscal first-quarter results showed a 16% revenue increase to $143.8 billion, driven largely by record iPhone sales of $85.3 billion. Despite strong fundamentals, investors remain cautious about Apple's valuation in an uncertain market environment. Live AAPL Chart 0.0000 MARKETS TREND [[AAPL-graph]] Despite a wider tech selloff, Apple shares are still rising, which is forcing investors to balance the company’s solid foundation against a more volatile and selective market environment. Apple Advances While the Tech Sector Stumbles Apple has emerged as a relative outperformer during a period of renewed stress across the technology and AI complex. Even as investors reassess valuations and trim exposure to higher-beta names, AAPL stock has continued to edge higher, underscoring its role as a perceived defensive anchor within the sector. On Wednesday, Apple shares climbed 2.6% to close at $276.40, sharply outperforming a 1.5% decline in the Nasdaq Composite. The gap between Apple and the broader tech index was the widest seen in roughly a year, highlighting a meaningful rotation rather than a broad-based rally. In an environment marked by heightened volatility, some investors appear to be seeking shelter in scale, balance-sheet strength, and proven cash generation. Still, the resilience has raised a familiar question: how much upside remains after a strong run, and how sustainable is the current momentum as market condition...
Lauren Elaina Friedman Stat, the director of Palantir Technologies (NASDAQ: PLTR), sold 400 shares of Palantir Technologies stock on Monday, February 2. The shares were sold at an average price of $151.14 with a total value of $60,456.00. After the transaction, Lauren now directly owns 58,287 shares of the company’s stock, valued at approximately $8,809,497.18. However, the trade was a 0.68% decre...
Lauren Elaina Friedman Stat, the director of Palantir Technologies (NASDAQ: PLTR), sold 400 shares of Palantir Technologies stock on Monday, February 2. The shares were sold at an average price of $151.14 with a total value of $60,456.00. After the transaction, Lauren now directly owns 58,287 shares of the company’s stock, valued at approximately $8,809,497.18. However, the trade was a 0.68% decrease in their position. The transaction was disclosed in a legal filing with the Securities and Exchange Commission (SEC). Palantir’s Strong Fundamentals as the Stock Sees Volatile Trading On Wednesday, the shares of Palantir Technologies stock traded down $18.34, hitting $139.54. 112,731,315 shares of the stock traded hands compared to the average volume of 42,078,484. The stock has a market cap of $332.59 billion, a P/E ratio of 221.50, a beta of 1.64, and a PEG ratio of 3.97. The 50-day moving average price of the firm was $175.20, and the 200-day moving average price was $173.49. Palantir Technologies Inc. had a 12-month low of $66.12 and a 12-month high of $207.52. The quarterly earnings of Palantir Technologies released on February 2nd reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.02. The business had a revenue of $1.41 billion during the quarter, compared to the analyst estimates of $1.34 billion. The firm had a net margin of 36.31% and a return on equity of 23.81%. Palantir Technologies’ quarterly revenue was up 70.0% compared to the same quarter last year, when the business earned $0.14 EPS. On average, the equities research analysts expect that Palantir Technologies Inc. will post 0.31 EPS for the current fiscal year. Related Insider Activity Alexander D. Moore also reported significant sales during this period. He sold 20,000 shares of Class A Common Stock in an unplanned transaction. On February 2nd of 2026, he executed multiple open-market sales that he entered on November 22, 2024. The sale was under a Ru...
Pandora A/S forecast slowing sales this year and said it will pause buybacks while reducing its exposure to volatile silver prices. The Danish jeweler expects organic sales to grow as much as 2% in a best-case scenario and to decline as much as 1% otherwise, in what would be the first sales drop since the pandemic. That missed analysts’ consensus of 3.9% growth. Share buybacks will be resumed once...
Pandora A/S forecast slowing sales this year and said it will pause buybacks while reducing its exposure to volatile silver prices. The Danish jeweler expects organic sales to grow as much as 2% in a best-case scenario and to decline as much as 1% otherwise, in what would be the first sales drop since the pandemic. That missed analysts’ consensus of 3.9% growth. Share buybacks will be resumed once it has made progress on plans to shift to platinum-plated jewelry, it added. “The US has slowed, silver prices are high, and costs could initially climb amid the disruption of plans to transition to some platinum-plating,” Bloomberg Intelligence analysts Deborah Aitken and Andrea Ferdinando Leggieri wrote in a note . Jefferies cut its recommendation on the stock to hold this week, leaving the jeweler with just four buys out of 22 ratings. The company is caught “between a rock and a hard place” as volatile silver prices and increasingly cautious consumers worsen existing margin pressures, analysts including Frederick Wild said. Pandora cut its organic revenue forecast for 2025 last month, as weak consumer sentiment in the US resulted in fewer shoppers visiting stores. The shares have slumped 28% since the start of 2026 through Wednesday’s close, and are among the biggest laggards in Europe’s Stoxx 600 Index this year. The stock saw some reprieve during a broad selloff in precious metals, though silver remains elevated against historical levels.
BNP Paribas SA ( BNPQY ) declares €2.57/share interim dividend. Payable May 20; for shareholders of record May 18; ex-div May 18. For 2026, BNP Paribas confirms its distribution policy, including a payout ratio of 60%, of which at least 50% in dividends and 10% in share buybacks. Beginning 2027, the payout ratio will be at least 60% and will be detailed at the 2027-2030 CMD. Distribution of surplu...
BNP Paribas SA ( BNPQY ) declares €2.57/share interim dividend. Payable May 20; for shareholders of record May 18; ex-div May 18. For 2026, BNP Paribas confirms its distribution policy, including a payout ratio of 60%, of which at least 50% in dividends and 10% in share buybacks. Beginning 2027, the payout ratio will be at least 60% and will be detailed at the 2027-2030 CMD. Distribution of surplus CET1 above 13% ratio will also be decided annually, starting in 2027. See BNPQY Dividend Scorecard, Yield Chart, & Dividend Growth. More on BNP Paribas SA BNP Paribas: Making Progress Towards A 13% ROTE In 2028 BNP Paribas SA reports Q4 results; confirms its 2024-2026 trajectory and 2028 targets raised Seeking Alpha’s Quant Rating on BNP Paribas SA Historical earnings data for BNP Paribas SA Dividend scorecard for BNP Paribas SA
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
Insight with Haslinda Amin, a daily news program featuring in-depth, high-profile interviews and analysis to give viewers the complete picture on the stories that matter. The show features prominent leaders spanning the worlds of business, finance, politics and culture. (Source: Bloomberg)
As the bodies of two dozen Palestinians killed in Israeli strikes arrived at hospitals in Gaza on Wednesday, the director of one asked a question that has echoed across the war-ravaged territory for months. “Where is the ceasefire? Where are the mediators?” Shifa Hospital’s Mohamed Abu Selmiya wrote on Facebook. At least 556 Palestinians have been killed in Israeli strikes since a US-brokered truc...
As the bodies of two dozen Palestinians killed in Israeli strikes arrived at hospitals in Gaza on Wednesday, the director of one asked a question that has echoed across the war-ravaged territory for months. “Where is the ceasefire? Where are the mediators?” Shifa Hospital’s Mohamed Abu Selmiya wrote on Facebook. At least 556 Palestinians have been killed in Israeli strikes since a US-brokered truce came into effect in October, including 24 on Wednesday and 30 on Saturday, according to Gaza’s Health Ministry. Advertisement Four Israeli soldiers have been killed in Gaza in the same period, with more injured, including a soldier whom the military said was severely wounded when militants opened fire near the ceasefire line in northern Gaza overnight. Palestinians make their way through the rubble of destroyed buildings in Gaza City. Photo: AFP Other aspects of the agreement have stalled, including the deployment of an international security force, Hamas’ disarmament and the start of Gaza’s reconstruction. The opening of the Rafah border crossing between Gaza and Egypt raised hope of further progress, but fewer than 50 people were allowed to cross on Monday.
Chaloemphan/iStock via Getty Images Summary During the fourth quarter of 2025, the Polen 5Perspectives Small Growth Composite Portfolio returned -1.3% gross and -1.5% net of fees, respectively, compared to the 1.2% return of the Russell 2000 Growth Index. The top contributors to relative performance in the period were Bloom Energy ( BE ), GeneDx ( WGS ), and Argan ( AGX ). The most significant det...
Chaloemphan/iStock via Getty Images Summary During the fourth quarter of 2025, the Polen 5Perspectives Small Growth Composite Portfolio returned -1.3% gross and -1.5% net of fees, respectively, compared to the 1.2% return of the Russell 2000 Growth Index. The top contributors to relative performance in the period were Bloom Energy ( BE ), GeneDx ( WGS ), and Argan ( AGX ). The most significant detractors from the Portfolio's relative performance in the quarter were Stride ( LRN ), Corcept Therapeutics ( CORT ), and Ramaco Resources ( METC ). After consecutive double digit returns in 2Q and 3Q, small caps – as defined by the Russell 2000 Growth Index – ended the year with a more modest 1.2% return in 4Q. Performance continued to broaden out beyond the AI theme, and Biotech in particular was a standout performer during the quarter. While the prospect of declining interest rates and improving earnings growth has driven more attention to the small cap asset class broadly, we remain most excited about structural tailwinds the asset class enjoys—most notably, the accelerating pace of innovation and the disruption and opportunity it presents for disciplined investors. Seeks Growth & Capital Preservation (Performance (%) as of 12-31-2025) Commentary In some ways, the fourth quarter of 2025 felt like a microcosm of the year overall. Similar to the tariff-related drawdown in the first quarter that gave way to a V-shaped recovery off the April lows, the fourth quarter featured a sharp 10% correction that was erased as quickly as it came with small caps returning to all-time highs later in the quarter. If AI has been the defining theme of market leadership in 2025, a big part of the sell-off in the early part of 4Q came down to growing concerns over the durability of that theme. As a result, the market rotated away from AI and AI adjacent industries like semis, electrical equipment, and tech hardware—much of which had benefitted from the surge higher in data center capex—and in...
Key Points Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? Medline looks primed and ready to continue delivering on its history of rapid, profitable sales growth 10 stocks we like better than Medline › Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? But, boring ca...
Key Points Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? Medline looks primed and ready to continue delivering on its history of rapid, profitable sales growth 10 stocks we like better than Medline › Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? But, boring can be beautiful, and Medline (MDLN) looks primed and ready to continue delivering on its history of rapid, profitable sales growth. Just the Facts Medline bills itself as "the largest provider of medical-surgical products and supply chain solutions serving all points of care." It boasts 335,00 products and 33 manufacturing facilities in more than 100 countries. 95% of customers here in the United States can receive next-day delivery. It therefore isn't much of an exaggeration to consider Medline the Amazon (AMZN) of medical and surgical ("medsurg") products. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Hospitals, surgery center, and physicians are among the main users of Medline's medical kits, surgical gloves, wound care, and lab supplies. A key competitive advantage is its namesake Medline Brand products, which count as private label and help boost margins. By serving as both the manufacturer and distributor, it gets to keep the margin another reseller might demand to get its products to market. Medline's M&A History Medline just went public, but was already publicly traded prior to a private buyout back in 2021. The buyout at the time was for $34 billion. The current initial public offering (IPO) was priced at $29 per share and raised $6.3 billion, which will be used to pay down debt. Medline's current valuation is $35.5 billion, or only slightly ahead of the valuation at which it was taken private. Based on the valuation multiple of EV/EBITDA, both the buyout and IPO are in the mid-...
ICE can't make warrantless arrests in Oregon unless there's risk of escape, judge rules toggle caption Jenny Kane/AP PORTLAND, Ore. — U.S. immigration agents in Oregon must stop arresting people without warrants unless there's a likelihood of escape, a federal judge ruled Wednesday. U.S. District Judge Mustafa Kasubhai issued a preliminary injunction in a proposed class-action lawsuit targeting th...
ICE can't make warrantless arrests in Oregon unless there's risk of escape, judge rules toggle caption Jenny Kane/AP PORTLAND, Ore. — U.S. immigration agents in Oregon must stop arresting people without warrants unless there's a likelihood of escape, a federal judge ruled Wednesday. U.S. District Judge Mustafa Kasubhai issued a preliminary injunction in a proposed class-action lawsuit targeting the Department of Homeland Security's practice of arresting immigrants they happen to come across while conducting ramped-up enforcement operations — which critics have described as "arrest first, justify later." The department, which is named as a defendant in the suit, did not immediately comment in response to a request from The Associated Press. Similar actions, including immigration agents entering private property without a warrant issued by a court, have drawn concern from civil rights groups across the country amid President Donald Trump's mass deportation efforts. Sponsor Message Courts in Colorado and Washington, D.C., have issued rulings like Kasubhai's, and the government has appealed them. In a memo last week, Todd Lyons, the acting head of U.S. Immigration and Customs Enforcement, emphasized that agents should not make an arrest without an administrative arrest warrant issued by a supervisor unless they develop probable cause to believe that the person is in the U.S. illegally and likely to escape from the scene before a warrant can be obtained. But the judge heard evidence that agents in Oregon have arrested people in immigration sweeps without such warrants or determining escape was likely. The daylong hearing included testimony from one plaintiff, Victor Cruz Gamez, a 56-year-old grandfather who has been in the U.S. since 1999. He told the court he was arrested and held in an immigration detention facility for three weeks even though he has a valid work permit and a pending visa application. Cruz Gamez testified that he was driving home from work in October w...